Develops biological reagents for life science research and diagnostics.
Jun 2026Revenue $1.22B/yrExpenses $963M/yr
No trend
Figures by year
Is BIO-TECHNE profitable?
Yes. In the 12 months to Jun 2026, revenue was $1.22B and expenses $963M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Jun 2026 | $1.22B | $963M | $252M |
| Jun 2025 | $1.22B | $1.12B | $102M |
| Jun 2024 | $1.16B | $952M | $207M |
| Jun 2023 | $1.14B | $838M | $299M |
| Jun 2022 | $1.11B | $809M | $297M |
| Jun 2021 | $931M | $694M | $237M |
| Jun 2020 | $739M | $581M | $157M |
| Jun 2019 | $714M | $567M | $147M |
| Jun 2018 | $643M | $507M | $136M |
| Jun 2017 | $563M | $442M | $121M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.